XNA16UK

N/A

Report date: 2025/09/05 13:27:30
NME

Base Information

Drug NameXNA16UK
Drug Alias NameXNA-16-UK
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionGrowth/differentiation factor 8 modulators
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenzhen Hard Nucleic Acid Biotechnology Co., Ltd.
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Hard Nucleic Acid Biotechnology Co., Ltd.
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A